Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Gastroenterology|October 13, 2006
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirinJean-Pierre Bronowicki, Denis Ouzan, Tarik Asselah, et al.
The New England Journal of Medicine|May 1, 2009
Telaprevir and peginterferon with or without ribavirin for chronic HCV infectionChristophe Hézode, Nicole Forestier, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)|March 19, 2013
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trialMark S Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, et al.
Hepatology (Baltimore, Md.)|December 7, 2011
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicitiesJean-Claude Trinchet, Cendrine Chaffaut, Valérie Bourcier, et al.
Antimicrobial Agents and Chemotherapy|July 2, 2014
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsCédric Laouénan, Patrick Marcellin, Martine Lapalus, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
Gastroenterology|June 25, 2011
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis CFrançois Habersetzer, Géraldine Honnet, Christine Bain, et al.
European Journal of Clinical Investigation|March 7, 2025
Mid-regional pro-adrenomedullin: A rapid sepsis biomarker for diagnosing spontaneous bacterial peritonitis in cirrhosisAbderrahim Oussalah, Vincent Haghnejad, Maël Silva Rodriguez, et al.
The New England Journal of Medicine|April 1, 2011
Boceprevir for untreated chronic HCV genotype 1 infectionFred Poordad, Jonathan McCone, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)|May 24, 2012
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirinIra M Jacobson, Patrick Marcellin, Stefan Zeuzem, et al.
Pageof 20